Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Highly-sensitized Kidney Transplant Recipients”

11 trials

Showing 11 of 11 results

Large-scale testing (Phase 3)Study completedNCT00682292
What this trial is testing

Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological Risk

Who this might be right for
Renal Transplantation
University Hospital, Lille 227
Testing effectiveness (Phase 2)Ended earlyNCT00090194
What this trial is testing

Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%

Who this might be right for
Kidney Failure, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT04827979
What this trial is testing

Daratumumab and Belatacept for Desensitization

Who this might be right for
Highly Sensitized Prospective Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 19
Not applicableUnknownNCT04414735
What this trial is testing

Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Fundacion Clinic per a la Recerca Biomédica 30
Testing effectiveness (Phase 2)WithdrawnNCT06461546
What this trial is testing

Imlifidase in Living Donor Renal Transplantation Highly Sensitized Recipients

Who this might be right for
Kidney Transplant Candidates
Fundacion Clinic per a la Recerca Biomédica
Not applicableStudy completedNCT00407160
What this trial is testing

A Trial of Tolerogenic Immunosuppression in Highly Sensitized Renal Transplant Recipients

Who this might be right for
Kidney Diseases
The University of Texas Medical Branch, Galveston 21
Early research (Phase 1)Not Yet RecruitingNCT06852625
What this trial is testing

Autologous Tolerogenic Dendritic Cells (ATDC) for Highly Sensitized Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Fundacion Clinic per a la Recerca Biomédica 30
Not applicableNot Yet RecruitingNCT07379957
What this trial is testing

Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Donor: Results of Kidney Transplantations Performed in Accordance to the French Guidelines.

Who this might be right for
Kidney Transplantation
University Hospital, Bordeaux 450
Testing effectiveness (Phase 2)Study completedNCT01911546
What this trial is testing

Role of Everolimus in Highly Sensitized Patients

Who this might be right for
Highly-sensitized Kidney Transplant Recipients
Joseph Kahwaji, MD, MPH 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05017545
What this trial is testing

Carfilzomib and Belatacept for Desensitization

Who this might be right for
Highly Sensitized Prospective Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 21
Post-approval studies (Phase 4)Study completedNCT03194321
What this trial is testing

Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients

Who this might be right for
End Stage Renal Disease
Cedars-Sinai Medical Center 20

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation